GSK Infanrix Combination Vaccine BLA Needs More U.S. Immunogenicity Data

Additional U.S. immunogenicity data should be collected on GlaxoSmithKline's Infanrix combination vaccine through a head-to-head comparison to the separately administered components, FDA's Vaccines & Related Biological Products Advisory Committee recommended March 7.